Origin donates fund to support Thai researcher toward the development of Coivid-19 mRNA Vaccine “ChulaCov19”
Mr. Somsakul Sangsuwan, Chief Design Officer of Origin Property Plc. had been company’s representative to donate fund to the Center of Excellence in Vaccine Research and Development, Chulalongkorn University (Chula VRC) which aims “to develop the Covid-19 mRNA vaccine to be used for Thais” worth 100,000 Baht, granted by Prof. Dr. Kiat Ruxrungtham, head of Chula VRC at Chulalongkorn Hospital.
The ChulaCov19 is first Covid-19 mRNA vaccine which has been researched and developed by Thais. And this has been shown the well-cooperation of various sectors, as well as it has supported by Prof. Drew Weissman, The Professor of Medicine from the University of Pennsylvania’s Perelman School of Medicine, USA.
Origin Property PCL operates three core businesses comprising
1. Residential Development Business. As of the end of Q2/2021, it has developed 86 housing and condominium projects with a total value of over 134 billion baht under PARK ORIGIN, The Origin, KnightsBridge, Notting Hill, Kensington and BRITANIA brands
2. Recurring Income Business. It develops and manages hotels, serviced apartments and retail spaces under One Origin Company Limited.
3. Service Business. It offers property management, property agent and consultancy services with a vision to expand into other businesses continuously and become an end-to-end property developer and solution provider.
